Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ATLG Levels and Immune Reconstitution Kinetics in Autologous HSCT for Multiple Sclerosis

NCT07635693 is registered in ClinicalTrials.gov with Ciceri Fabio as lead sponsor.

NCT NCT07635693
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07635693 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ATLG Levels and Immune Reconstitution Kinetics in Autologous HSCT for Multiple Sclerosis
Lead sponsor
Ciceri Fabio
Phase
Observational
Overall status
Recruiting
Start date
May 4, 2026
Completion date
May 4, 2029
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atlg, autologous hematopoietic stem cell transplant, multiple sclerosis